strategies for treatment-resistant depression
May 2006
New evidence will improve strategies for treatment-resistant depression. More than HALF of patients continue to have symptoms after initial treatment for depression.
Switching to a different antidepressant is helpful in about 25% of patients who don't respond to an SSRI.
A patient may not even need to switch to a different class. For example, patients who don't respond to citalopram are as likely to respond to sertraline as they are to venlafaxine or bupropion.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote